News
Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for the updated formulation of the COVID-19 vaccine Spikevax®, targeting the ...
The global health community faces a deepening challenge—not only from infectious diseases but also from a pandemic of ...
There have been lots of changes to COVID vaccine recommendations. Here is the current vaccine schedule for people 6 months to 65+ years old.
Merck Q2 earnings beat estimates but revenue fell short. Gardasil sales dropped while Keytruda and other treatments drove ...
17h
Zacks Investment Research on MSNMerck Unveils Cost-Cutting Plan: Can it Create Long-Term Value?
Along with its second-quarter results on July 29, Merck MRK announced a new multi-year optimization initiative, which is ...
The new vaccinations could be self-administered at home, with the floss approach also thought compatible with flu, hepatitis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results